Invion Ltd (IVX)

Sydney
0.009
+0.001(+12.50%)
  • Volume:
    452,761
  • Bid/Ask:
    0.009/0.009
  • Day's Range:
    0.009 - 0.009

IVX Overview

Prev. Close
0.008
Day's Range
0.009-0.009
Revenue
2.3M
Open
0.009
52 wk Range
0.008-0.019
EPS
0
Volume
452,761
Market Cap
57.78M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,112,244
P/E Ratio
-22.56
Beta
1.49
1-Year Change
-52.63%
Shares Outstanding
6,420,092,081
Next Earnings Date
-
What is your sentiment on Invion Ltd?
or
Market is currently closed. Voting is open during market hours.

Invion Ltd News

Invion Ltd Company Profile

Invion Ltd Company Profile

Invion Limited is an Australia-based life-sciences company. The Company is focused on the development of Photosoft technology for the treatment of a range of cancers, atherosclerosis, and infectious diseases. The Company’s Photo Dynamic Therapy (PDT) is a treatment that optimizes the use of non-toxic photosensitizers and visible light to kill cancer and stimulate the immune system. The Company’s PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. It produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. It is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsNeutralNeutralNeutralSellStrong Sell
SummarySellSellSellStrong SellStrong Sell